Dublin, Ireland
We are a biotech longevity company on a mission to confront aging and age-related diseases. We’re building a coalition of the best scientists, physicians and investors to develop therapies and products that will help people experience better health for longer in their lives. We are organized to drive scientific innovation with speed and agility to market.
11
Total Investments
5
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biopharma, Biotechnology +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Juvenescence
Recent Investments (11)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Oct 2023 | |
| Seed | •••••• | Feb 2023 | |
| Series A | •••••• | Mar 2022 | |
| Convertible Note | •••••• | Dec 2020 | |
| Seed | •••••• | Jan 2020 | |
•••• ••••
|
Debt Financing | •••••• | Oct 2019 |
|
•••• ••••
|
Series B | •••••• | Sep 2019 |
|
•••• ••••
|
Private Equity Round | •••••• | Sep 2018 |
|
•••• ••••
|
Private Equity Round | •••••• | Jun 2018 |
|
•••• ••••
|
Series A | •••••• | Jun 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
